News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
311,137 Results
Type
Article (17237)
Company Profile (48)
Press Release (293837)
Multimedia
Podcasts (103)
Webinars (12)
Section
Business (95452)
Career Advice (653)
Deals (15304)
Drug Delivery (113)
Drug Development (40672)
Employer Resources (50)
FDA (6870)
Job Trends (6465)
News (146268)
Policy (12010)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Digital (1)
2027 Pharm Country Standard (4)
Academia (882)
Accelerated approval (44)
ADA (40)
Adcomms (24)
Allergies (122)
Alliances (17109)
ALS (181)
Alzheimer's disease (1200)
Antibody-drug conjugate (ADC) (429)
Approvals (7427)
Artificial intelligence (561)
ASCO (258)
Autoimmune disease (273)
Automation (41)
Bankruptcy (140)
Belgium (9)
Best Places to Work (5393)
BIO (44)
Biologics (14)
BIOSECURE Act (12)
Biosimilars (196)
BioSpace Insights (70)
Biotechnology (30)
Bispecific (4)
Bladder cancer (184)
Brain cancer (47)
Breast cancer (575)
Cancer (4769)
Cardiovascular disease (429)
Career advice (552)
Career pathing (30)
CAR-T (185)
CDC (24)
CDMO (117)
Celiac Disease (1)
Cell-line development (1)
Cell therapy (559)
Cervical cancer (42)
Clinical research (38415)
Collaboration (1579)
Commercialization (14)
Company closure (6)
Compensation (749)
Complete response letters (53)
COVID-19 (947)
CRISPR (73)
C-suite (869)
Cystic fibrosis (99)
Data (6584)
Decentralized trials (2)
Denatured (15)
Depression (109)
Dermatology (124)
Diabetes (426)
Diagnostics (2680)
Digital health (37)
Diversity (9)
Diversity, equity & inclusion (12)
Drug discovery (277)
Drug pricing (181)
Drug shortages (26)
Duchenne muscular dystrophy (232)
Earnings (47028)
Editorial (57)
Employer branding (6)
Employer resources (55)
Events (65992)
Executive appointments (754)
Eye disease (1)
FDA (9623)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (14)
Frontotemporal dementia (20)
Funding (1157)
Gene editing (150)
Generative AI (54)
Gene therapy (429)
GLP-1 (772)
Government (1857)
Grass and pollen (5)
Guidances (286)
Healthcare (7548)
Hematology (101)
HIV (85)
Huntington's disease (42)
Idiopathic pulmonary fibrosis (4)
IgA nephropathy (94)
Immunology and inflammation (262)
Immuno-oncology (97)
Indications (173)
Infectious disease (1175)
Inflammatory bowel disease (149)
Inflation Reduction Act (10)
Influenza (68)
Intellectual property (163)
Interviews (100)
IPO (7548)
IRA (45)
Job creations (1274)
Job search strategy (458)
JPM (61)
Kidney cancer (19)
Kidney disease (49)
Labor market (87)
Layoffs (293)
Leadership (37)
Legal (2505)
Licensing (32)
Liver cancer (72)
Longevity (22)
Lung cancer (773)
Lung diease (14)
Lymphoma (364)
Machine learning (53)
Management (26)
Manufacturing (792)
Marketing (11)
MASH (164)
Medical affairs (2)
Medical device (4942)
Medtech (5052)
Mergers & acquisitions (8594)
Metabolic disorders (1201)
mRNA (137)
Multiple sclerosis (150)
NASH (18)
Netherlands (5)
Neurodegenerative disease (346)
Neuropsychiatric disorders (85)
Neuroscience (2390)
Neurotech (1)
NextGen: Class of 2026 (2168)
Non-profit (1469)
Now hiring (61)
Obesity (605)
Opinion (196)
Ovarian cancer (143)
Pain (191)
Pancreatic cancer (270)
Parkinson's disease (269)
Partnered (15)
Patents (343)
Patient advocacy (1)
Patient recruitment (515)
Patient selection (15)
Peanut (37)
People (23050)
Peptides (6)
Pharmaceutical (20)
Pharmacy benefit managers (28)
Phase 1 (10129)
Phase 2 (16459)
Phase 3 (14759)
Pipeline (7749)
Policy (231)
Postmarket research (1394)
Preclinical (4284)
Press Release (14)
Prostate cancer (253)
Psychedelics (44)
Radiopharmaceuticals (224)
Rare diseases (828)
Real estate (1979)
Recruiting (25)
Regenerative medicine (5)
Regulatory (11447)
Reports (29)
Research institute (916)
Resumes & cover letters (117)
Rett syndrome (41)
RNA editing (14)
RSV (66)
Schizophrenia (137)
Series A (196)
Series B (140)
Service/supplier (5)
Sickle cell disease (81)
Special edition (27)
Spinal muscular atrophy (88)
Sponsored (26)
Startups (1311)
Stomach cancer (19)
Substance use disorders (10)
Supply chain (90)
Tariffs (98)
The Weekly (86)
Vaccines (535)
Venture capital (114)
Weight loss (431)
Wet AMD (1)
Women's health (107)
Worklife (10)
Date
Today (25)
Last 7 days (378)
Last 30 days (1494)
Last 365 days (18958)
2026 (14250)
2025 (19033)
2024 (18044)
2023 (18875)
2022 (23713)
2021 (24097)
2020 (22323)
2019 (18794)
2018 (14365)
2017 (14566)
2016 (13887)
2015 (16344)
2014 (11749)
2013 (9266)
2012 (10016)
2011 (10453)
2010 (9085)
Location
Africa (281)
Alabama (31)
Alaska (1)
Arizona (128)
Arkansas (6)
Asia (18479)
Australia (2483)
California (9351)
Canada (2121)
China (1163)
Colorado (372)
Connecticut (430)
Delaware (342)
Europe (44897)
Florida (1205)
Georgia (242)
Hawaii (4)
Idaho (20)
Illinois (791)
India (95)
Indiana (395)
Iowa (15)
Japan (596)
Kansas (73)
Kentucky (31)
Louisiana (53)
Maine (29)
Maryland (1040)
Massachusetts (6759)
Michigan (178)
Minnesota (405)
Mississippi (3)
Missouri (123)
Montana (3)
Nebraska (9)
Nevada (134)
New Hampshire (34)
New Jersey (2644)
New Mexico (25)
New York (2292)
North Carolina (932)
North Dakota (6)
Northern California (4663)
Ohio (252)
Oklahoma (11)
Oregon (19)
Pennsylvania (2607)
Puerto Rico (25)
Rhode Island (22)
South America (434)
South Carolina (15)
Southern California (3856)
Tennessee (141)
Texas (1353)
United States (32466)
Utah (208)
Vermont (1)
Virginia (209)
Washington D.C. (46)
Washington State (735)
West Virginia (2)
Wisconsin (132)
Wyoming (1)
311,137 Results for "purdue pharma l p".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GCAR and Purdue Pharma L.P. Announce Initiation of Tinostamustine in GBM AGILE Trial
April 8, 2026
·
6 min read
Press Releases
Icahn Enterprises L.P. Announces Q2 2026 Earnings Conference Call
July 24, 2026
·
1 min read
Press Releases
Inside the 98 Percent: L7 Informatics on the Operational Harness That Determines Pharma’s Agentic AI Outcomes
L7 Informatics CEO, Vasu Rangadass, Ph.D., examines the architectural principle separating pharmaceutical AI experimentation from enterprise-scale deployment.
June 12, 2026
·
1 min read
Press Releases
L7 Informatics Makes the Case for “CMC-in-the-Loop” as AI Outpaces Pharma’s Traditional Manufacturing Handoffs
September 23, 2026
·
1 min read
Pharm Country
Purdue Pharma L.P. Awards Grant for Investigator-initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
Purdue Pharma L.P. (“Purdue”) announced today that the Company has awarded an investigator-initiated research (IIR) grant to a team of researchers at The University of New Mexico (UNM) for the evaluation of nalmefene hydrochloride (HCl) injection 2mg/2mL (1mg/1mL) in the emergency department setting.
March 27, 2024
·
7 min read
Press Releases
L7 Informatics Challenges the Notion of the “AI Governance Layer” in Pharma
July 22, 2026
·
1 min read
Press Releases
AINN-P1: Small Model, Big Intelligence
AINN-P1: Small Model, Big IntelligenceHow does a 167M-parameter protein foundation model outperform a 650M general-purpose model on the tasks that matter?
September 10, 2026
·
1 min read
Press Releases
L7 Informatics Advocates for Neuro-Symbolic AI in Regulated Life Sciences
L7 Informatics’ position is that generative AI has been deployed in regulated science with only half the architecture it needs, and that the missing half is an active knowledge graph generated at the point of execution.
July 23, 2026
·
1 min read
Press Releases
Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O’Grady as Chief Executive Officer to Lead Strategic Growth
July 28, 2026
·
5 min read
Pharm Country
Purdue Pharma L.P. to Provide Funding Opportunities for Investigator-Initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
Purdue Pharma L.P. is accepting proposals for investigator-initiated research (IIR) to examine the outcomes associated with the use of Nalmefene Hydrochloride injection, 2mg/2mL (1mg/1mL).
March 28, 2023
·
6 min read
1 of 31,114
Next
